Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Multiple myeloma

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

Mailee Huynh, Hae Yeun Chang, [ ... ], Shigeki Miyamoto

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma

Dollapak Apipongrat, Sittiruk Roytrakul, [ ... ], Oytip Nathalang

Prevalence of corneal findings and their interrelation with hematological findings in monoclonal gammopathy

Mohammad Al Hariri, Markus Munder, [ ... ], Joanna Wasielica-Poslednik

LTβR overexpression promotes plasma cell accumulation

Jessica A. Kotov, Ying Xu, Nicholas D. Carey, Jason G. Cyster

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017

Amal AlZahmi, Irena Cenzer, [ ... ], Karin Berger

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort

Nadjoua Maouche, Bhuvan Kishore, [ ... ], Karthik Ramasamy

Vγ9Vδ2 T cells expressing a BCMA—Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth

Xi Zhang, Yu Yang Ng, [ ... ], Shu Wang

Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma

Patrick Daniele, Carla Mamolo, [ ... ], Anna Forsythe

Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients

Jillian C. Thompson, Yi Ren, [ ... ], Anthony D. Sung

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling

Sook-Kyoung Heo, Eui-Kyu Noh, [ ... ], Jae-Cheol Jo

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)

Anshul Agarwal, Aakanksha Khandelwal, [ ... ], Indraneel Mittra

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM

Hyunkyung Park, Ja Min Byun, [ ... ], Inho Kim

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients

Faouzi Djebbari, Alexandros Rampotas, [ ... ], Karthik Ramasamy

Advertisement

Create a weekly email alert for: Multiple myeloma

You can change these options by clicking profile then "Alerts and Notifications"